LivaNova plc Stock
LivaNova plc Stock
There is an upward development for LivaNova plc compared to yesterday, with an increase of €1.50 (2.830%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on LivaNova plc.
As a result the target price of 59 € shows a slightly positive potential of 8.26% compared to the current price of 54.5 € for LivaNova plc.
Pros and Cons of LivaNova plc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | 2.830% | -3.636% | 3.922% | 80.272% | 0.952% | 37.306% | -21.481% |
| Bio-Rad Labs Inc. A | 0.500% | 1.913% | 4.970% | 7.692% | -5.002% | -44.268% | -51.961% |
| CONMED Corp. | 4.490% | 3.333% | -4.321% | -33.476% | -11.429% | -68.367% | -72.321% |
| Neogen Corp. | -3.290% | -3.503% | -2.900% | 57.886% | 26.309% | - | - |
Comments
LivaNova (LIVN) had its price target raised by Needham & Company LLC from $64.00 to $81.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat